Interpretation is dependent on clinical situation, apixaban dose and timing of the test.
Apixaban levels <50 ng/ml = likely NO clinically significant anticoagulant effect.
Results must be discussed with Clinical Haematology, click here for contact details.
Interpretation of apixaban levels is challenging for many reasons; including limited established therapeutic ranges and lack of high-quality evidence on how test results should guide individual patient care.
Indication |
Dose apixaban |
Peak (ng/ml) (5th – 95th percentile) |
Trough (ng/ml) (5th – 95th percentile) |
AF |
5mg BD |
171 (91-321) |
103 (41-230) |
2.5mg BD |
123 (69-221) |
|
|
Treatment PE/DVT |
5mg BD |
132 (59-302) |
63 (22-177) |
2.5mg BD |
67 (30-153) |
|
Expected plasma concentrations for apixaban according to clinical indication, dose and timing (2025 Mithoowani, 2024 Baker/British Society Haematology)